PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies

International Journal of Pharmaceutics

Volumn 352, Issue 1-2, 2008, Pages 50-57

  Fernandez Carballido A ^a   Pastoriza, P ^a   Barcia, E ^a   Montejo, C ^b   Negro, S ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Cell viability; Microspheres; PLGA PEG derivative

Indexed keywords

MICROSPHERE; OLEIC ACID; POLYGLACTIN; POLYMER; POLYOXYETHYLATED OLEIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ANALYSIS; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED RADIATION; LEUKOCYTE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; FIBROBLASTS; GLYCERIDES; GLYCOLATES; HUMANS; LEUKOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; NIH 3T3 CELLS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POROSITY; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, INFRARED; SPLEEN; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 39449086491     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.10.007     Document Type: Article

References (29)

1. Alléman E., Gurny R., and Leroux J.C. Biodegradable nanoparticles of PLA and PLGA for parenteral administration. In: Lieberman H.A., Rieger M.M., and Banker G.S. (Eds). Pharmaceutical Dosage Forms: Disperse Systems. second ed. (1998), Marcel Dekker, New York
2. Bao W., Zhou J., Luo J., and Wu D. PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. J. Microencapsul. 23 (2006) 471-479
3. Berkland C., King M., Cos A., Kim K., and Pack D.W. Precise control of PLG microspheres size provides enhanced control of drug release rate. J. Control. Release 82 (2002) 137-147
4. Blanco-Prieto M.J., Besseghir K., Zerbe O., Andris D., Orsolini P., Heingartiner F., Merkle H.P., and Gander B. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. J. Control Release 67 (2000) 19-28
5. Choi Y., Kim S.Y., Kim S.H., Lee K.S., Kim C., and Byun Y. Long-term delivery of all- trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. Int. J. Pharm. 215 (2001) 67-81
6. Chung T.W., Tsai Y.L., Hsieh J.H., and Tsai W.J. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J. Microencapsul. 23 (2006) 15-27
7. Fernández-Carballido A., Herrero-Vanrell R., Molina, Martínez I.T., and Pastoriza P. Biodegradable ibuprofen loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Int. J. Pharm. 27 (2004) 33-41
8. Gander B., Meinel M., Walter E., and Merkle H.P. Polymers an a platform for drug delivery: reviewing our current portfolio on poly (lactide-co-glycolide) (PLGA) microspheres. Chimia 55 (2001) 212-217
9. Hausburger A.G., Kenley R.A., and Deluca P.P. Gamma irradiation effects on molecular weight and in vitro degradation of poly (D,L-lactide-co-glycolide) microparticles. Pharm. Res. 12 (1995) 851-856
10. Houghton P., Fang R., Tecgatanawat I., Steventon G., Hylands P.J., and Lee C.C. Methods 42 (2007) 377-387
11. Herrero-Vanrell R., Ramírez L., Fernández-Carballido A., and Refojo M. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in-vitro release profiles and sterilization process. Pharm. Res. 17 (2000) 1323-1328
12. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lacide-co-glycolide) (PLGA) devices. Biomaterials 21 (2000) 2475-2490
13. Lecaroz C., Gamazo C., Renedo M.J., and Blanco-Prieto M.J. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J. Microencapsul. 23 (2006) 782-792
14. Mallard C., Coudane J., Rault I., and Vert M. The use of additives to modulate the release of sparingly water soluble drug entrapped in PLA50 microparticles. J. Microencapsul. 17 (2000) 81-93
15. Mallardé D., Boutignon F., Moine F., Barré E., David S., Touchet H., Ferruti P., and Deghenghi R. PLGA-PEG microspheres of teverelix: influence of polymer type on microspheres characteristics and on teverelix in vitro release. Int. J. Pharm. 261 (2003) 69-80
16. Mannerströma M., Toimelaa T., Ylikomia Y., and Tähti H. The combined use of human neural and liver cell lines and mouse hepatocytes improves the predictability of the neurotoxicity of selected drugs. Toxicol. Lett. 165 (2006) 195-202
17. Martínez-Sancho C., Herrero-Vanrell R., and Negro S. Poly (d,l, lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives. J. Microencapsul. 20 (2003) 799-810
18. Martínez-Sancho C., Herrero-Vanrell R., and Negro S. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release. Int. J. Pharm. 326 (2006) 100-106
19. Mi F.L., Shyu S.S., Lin Y.M., Wu Y.B., Peng C.K., and Tsai Y.H. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials 24 (2003) 5023-5036
20. Moutabarrik A., Mourid M., and Nakanishi I. The effect of organ preservation solutions on kidney tubular and endothelial cells. Transpl. Int. 11 (1998) 58-62
21. Puebla P., Pastoriza P., Barcia E., and Fernández-Carballido A. PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intraarticular administration. J. Microencapsul. 22 (2005) 793-808
22. Ruan G., and Feng S.S. Preparation and characterization of poly(lactic acid)-pole(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24 (2003) 5037-5044
23. Sansdrap P., and Moës A.J. Influence of additives on the release profile of nifedipine from poly(dl-lactide-co-glycolide) microspheres. J. Microencapsul. 15 (1998) 545-553
24. Siepmann J., Faisant N., Akiki J.J., Richard J., and Benoit J.P. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J. Control. Release 96 (2004) 123-134
25. Srinivasan C., Katare Y.K., Muthukumaran T., and Panda A.K. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles. J. Microencapsul. 22 (2005) 127-138
26. Venkatraman S.S., Jie P., Min F., Freddy B.Y.C., and Leong-Huast G. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. Int. J. Pharm. 298 (2005) 219-232
27. Wang N., Wu X.S., Li C., and Feng M.F. Synthesis, characterisation, biodegradation and drug delivery application of biodegradable lactic/glycolic polymers: synthesis and characterisation. J. Biomater. Sci. Polymer Ed. 11 (2000) 301-318
28. Wischke C., and Borchert H.H. Influence of the primary emulsification procedure on the characteristics of small protein-loaded PLGA microparticles for antigen delivery. J. Microencapsul. 23 (2006) 435-448
29. Zheng C.H., Gao J.Q., Liang W.Q., Yu H.Y., and Zhang Y.L. Effects of additives and processing parameters on the initial burst release of protein from poly(lactic-co-glycolic acid) microspheres. PDA J. Pharm. Sci. Tech. 60 (2006) 54-59